Exploring MFN Policy Effectiveness in Drug Pric...

By João L. Carapinha

February 19, 2026

MFN Policy Effectiveness in Countering Freeloading Claims The MFN policy effectiveness is evident in the coalition letter dated February 12, 2026, which opposes codifying Mos...
Zorginstituut Nederland’s Lecanemab Health Insurance Rejection: Implica...
Disrupting Prescription Drug Pricing: Mark Cuban’s Cost-Plus Vision
Strategic Vision and Infarmed 2026 Priorities for Regulatory Reform
Tislelizumab NSCLC Inclusion Recommended for Dutch Health Package
Launch of TrumpRx Drug Pricing: Savings on Essential Medications
Ozempic Public Funding Approval in Portugal: Key Insights and Implications
Accelerating FAST-EU Clinical Trials
Trump Economic Revival: Key Policies and Impacts from Davos 2026
Navigating Economic Resilience Through Life Sciences Investment
Guiding Principles for Ethical AI Integration in Drug Development
EU Launches Joint Scientific Consultations to Enhance Health Technology Asses...
NHS Cost-Effectiveness Thresholds Boost Drug Approvals and Innovation